Kevin Donovan, MD
Hospitalist · Maryville, TNNPI 1073969150
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 46 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 46 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$135
- Pfizer$135
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$114
- La Jolla Pharmaceutical Company$100
- E.r. Squibb & Sons, L.L.C.$88
- AbbVie$80
- plus $398 from 12 others
What the payments were for
- Food & beverage$1,050100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 1 | $135 |
| Pfizer | 6 | $135 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $114 |
| La Jolla Pharmaceutical Company | 4 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $88 |
| AbbVie | 5 | $80 |
| Merck | 3 | $76 |
| AstraZeneca(2 entities) | 4 | $67 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $43 |
| Novartis | 2 | $37 |
| Johnson & Johnson | 2 | $32 |
| Gilead | 2 | $30 |
| UCB, Inc. | 1 | $29 |
| Vertex | 1 | $23 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Boston Scientific | 1 | $16 |
| Incyte Corporation | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $12 |
How this compares
$1,050 in reported general payments places this provider in the 85th percentile of 349 hospitalist providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 40 | $355 |
| Prednisone | 29 | $255 |
| Oxycodone Hcl | 12 | $55 |
| Azithromycin | 18 | $49 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Maryville
- Jennifer WinbiglerMaryville$3K
- Teresa Salazar-CatronMaryville$2K
- Kimberly GoodemoteMaryville$1K
- Nathaniel RunneMaryville$1K
- Gerald OnuohaNashville$37K
- Sunil KripalaniNashville$23K
- Ankur SethMemphis$13K
- Eugene ScobeyMemphis$6K
- Monico BanezJackson$6K
- Omar AlsharifKnoxville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.